HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€6.08
Day range
€5.94 - €6.08
Year range
€2.89 - €13.30
Market cap
167.42M EUR
Avg Volume
15.25K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.32M | 142.55% |
Operating expense | 4.23M | 7.37% |
Net income | -1.74M | 38.01% |
Net profit margin | -75.11 | 74.44% |
Earnings per share | — | — |
EBITDA | -1.81M | 37.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.96M | -29.49% |
Total assets | 45.44M | -20.67% |
Total liabilities | 10.78M | 26.04% |
Total equity | 34.66M | — |
Shares outstanding | 29.04M | — |
Price to book | 5.11 | — |
Return on assets | -10.81% | — |
Return on capital | -13.44% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.74M | 38.01% |
Cash from operations | -1.68M | 19.13% |
Cash from investing | 193.00K | -92.14% |
Cash from financing | -4.50K | 85.71% |
Net change in cash | -1.49M | -523.93% |
Free cash flow | -1.60M | 9.65% |
About
Founded
2012
Website
Employees
41
